Literature DB >> 27853631

Stepping back to move forward: a current review of iPSCs in the fight against Alzheimer's disease.

Aditya Devineni1, Scarlett Tohme1, Michael T Kody1, R Adams Cowley1, Brent T Harris1.   

Abstract

The successful generation of the first iPSCs about ten years ago has provided deeper insight into previously unknown disease mechanisms and therapeutic opportunities for many diseases. In particular, iPSCs are becoming an important tool in advancing modeling and therapeutic intervention for Alzheimer's disease. In this manuscript, we assess the research climate surrounding the application of iPSCs to familial and sporadic Alzheimer's disease, including the generation and isolation of individualized neural stem cells, the introduction of neural stem cell transplants using iPSCs, and an estimation of the potential use of iPSCs as research models for Alzheimer's treatments and therapies. The clinical application of stem cells in the treatment of Alzheimer's disease appears promising, but much of the recent experimentation has been conducted using animal models or embryonic stem cells. As induced pluripotent stem cell research advances, iPSCs will likely provide investigators with a more applicable tool to progress advances in research and treatment for Alzheimer's and other neurodegenerative diseases.

Entities:  

Keywords:  Alzheimer’s disease; IPSC; induced pluripotent stem cell

Year:  2016        PMID: 27853631      PMCID: PMC5107654     

Source DB:  PubMed          Journal:  Am J Stem Cells        ISSN: 2160-4150


  32 in total

1.  Dissecting risk haplotypes in sporadic Alzheimer's disease.

Authors:  Frank Soldner; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2015-04-02       Impact factor: 24.633

Review 2.  [Cellular models for individualized medicine in Alzheimer's disease using patient-derived induced pluripotent stem cells].

Authors:  Masashi Asai; Keiro Shirotani; Takayuki Kondo; Haruhisa Inoue; Nobuhisa Iwata
Journal:  Nihon Yakurigaku Zasshi       Date:  2014-01

3.  Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." Addressing the challenge of Alzheimer's disease in the 21st century.

Authors:  Karl Herrup
Journal:  Alzheimers Dement       Date:  2011-05       Impact factor: 21.566

4.  Notch1 and its ligands Delta-like and Jagged are expressed and active in distinct cell populations in the postnatal mouse brain.

Authors:  Gila Stump; André Durrer; Anne-Laurence Klein; Simone Lütolf; Ueli Suter; Verdon Taylor
Journal:  Mech Dev       Date:  2002-06       Impact factor: 1.882

5.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease.

Authors:  Clemens R Scherzer; Katrin Offe; Marla Gearing; Howard D Rees; Guofu Fang; Craig J Heilman; Chica Schaller; Hideaki Bujo; Allan I Levey; James J Lah
Journal:  Arch Neurol       Date:  2004-08

6.  The generation of definitive neural stem cells from PiggyBac transposon-induced pluripotent stem cells can be enhanced by induction of the NOTCH signaling pathway.

Authors:  Ryan P Salewski; Josef Buttigieg; Robert A Mitchell; Derek van der Kooy; Andras Nagy; Michael G Fehlings
Journal:  Stem Cells Dev       Date:  2012-09-17       Impact factor: 3.272

Review 7.  Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.

Authors:  N Popovic; P Brundin
Journal:  Int J Pharm       Date:  2006-03-10       Impact factor: 5.875

8.  Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts.

Authors:  Corey Heffernan; Huseyin Sumer; Luis F Malaver-Ortega; Paul J Verma
Journal:  Stem Cells Int       Date:  2012-04-26       Impact factor: 5.443

9.  Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences.

Authors:  Simon R Smukler; Susan B Runciman; Shunbin Xu; Derek van der Kooy
Journal:  J Cell Biol       Date:  2006-01-02       Impact factor: 10.539

10.  Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.

Authors:  Mason A Israel; Shauna H Yuan; Cedric Bardy; Sol M Reyna; Yangling Mu; Cheryl Herrera; Michael P Hefferan; Sebastiaan Van Gorp; Kristopher L Nazor; Francesca S Boscolo; Christian T Carson; Louise C Laurent; Martin Marsala; Fred H Gage; Anne M Remes; Edward H Koo; Lawrence S B Goldstein
Journal:  Nature       Date:  2012-01-25       Impact factor: 49.962

View more
  3 in total

1.  In Vitro Models of the Human Blood-Brain Barrier Utilising Human Induced Pluripotent Stem Cells: Opportunities and Challenges.

Authors:  Iqra Pervaiz; Abraham J Al-Ahmad
Journal:  Methods Mol Biol       Date:  2022

Review 2.  The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease.

Authors:  Robert A Culibrk; Mariah S Hahn
Journal:  Front Aging Neurosci       Date:  2020-12-07       Impact factor: 5.750

Review 3.  Representing Diversity in the Dish: Using Patient-Derived in Vitro Models to Recreate the Heterogeneity of Neurological Disease.

Authors:  Layla T Ghaffari; Alexander Starr; Andrew T Nelson; Rita Sattler
Journal:  Front Neurosci       Date:  2018-02-09       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.